MULTIMODAL BIOCHEMICAL MODULATION OF 5-FLUOROURACIL BY LEUCOVORIN, METHOTREXATE, AND INTERFERON-ALPHA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

Citation
S. Cascinu et al., MULTIMODAL BIOCHEMICAL MODULATION OF 5-FLUOROURACIL BY LEUCOVORIN, METHOTREXATE, AND INTERFERON-ALPHA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 385-386
Citations number
15
Categorie Soggetti
Pharmacology & Pharmacy",Oncology
ISSN journal
03445704
Volume
38
Issue
4
Year of publication
1996
Pages
385 - 386
Database
ISI
SICI code
0344-5704(1996)38:4<385:MBMO5B>2.0.ZU;2-F
Abstract
A total of 26 patients with advanced colorectal cancer received 60 mg/ m(2) methotrexate i.v. on days 1-4; 400 mg/m(2) 5-fluorouracil i.v. on days 2, 3, 5, and 6; and 100 mg/m(2) 6S-leucovorin i.v. on days 2, 3, 5, and 6. Interferon-alpha 2b at a dose of 3 million U was given i.m. daily for the 6 days of chemotherapy. Courses were repeated every 3 w eeks. There were four partial responses for a response rate of 15% (95 % confidence interval 2-28%). In all, 14 patients expressed grade 3 to xicity; 9 patients had diarrhea, 3 had stomatitis, and 2 developed leu kopenia. In conclusion, multimodal biochemical modulation of 5-fluorou racil, at least on this schedule, does not seem to be effective, as it results in severe toxicity.